tirzepatide versus retatrutide vs #tirzepatide at a glance… #onthepen Retatrutide vs Tirzepatide — Key

Preliminary data from our laboratories suggest that obesity and NAFLD may induce hyperglucagonemia via distinct mechanisms, potentially related to elevated amino acid and fatty acid levels that disrupt the liveralpha cell axis, as seen in NAFLD 86

In addition to mimicking GLP-1, tirzepatide mimics another gut hormone called gastric inhibitory polypeptide, or GIP, that scientists believe has a similar effect on the body as GLP-1

This included remission from obesity in 15 percent of the participants given semaglutide versus just 3 percent of those taking placebo

Protein-free diets do not protect high-incidence diabetes-prone BioBreeding rats from diabetes

Proc Am Assoc Cancer Res 23(16S), 2005